Supplementary Figure 2 from Novel ATP-Competitive MEK Inhibitor E6201 Is Effective against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model

Abstract

<p>PDF - 164K, MAPK pathway inhibitory activity of the test compounds in G361.</p>